Recent Updates
Recently added Catalysts
ANRO Negative Sentiment Score: 25/100

Alto Neuroscience, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before September 19, 2025 to Discuss Your Rights – ANRO

Key Takeaway: A class action lawsuit has been filed against Alto Neuroscience, Inc. alleging securities fraud concerning the company's product pipeline, specifically ALTO-100. Investors who purchased shares during the initial public offering and subsequent period may be eligible to recover losses. The lawsuit claims that the company's statements about the effectiveness and commercial prospects of ALTO-100 were misleading. Affected investors have until September 19, 2025, to act.

Market Sentiment Analysis

POSITIVE FACTORS

  • Potential for compensation for affected investors without upfront costs.
  • Experienced legal team with a strong track record in securities litigation.

CONCERNS & RISKS

  • Allegations of securities fraud against Alto Neuroscience, Inc.
  • Claims that product pipeline ALTO-100 is less effective than previously stated.
  • Overstated clinical, regulatory, and commercial prospects affecting investor trust.

Full Press Release Details

NEW YORK, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Alto Neuroscience, Inc. ("Alto Neuroscience, Inc." or the "Company") (NYSE: ANRO) of a class action securities lawsuit.
CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Alto Neuroscience, Inc. investors who were adversely affected by alleged securities fraud. This lawsuit is on behalf of a class consisting of all persons and entities that purchased or otherwise acquired: (a) Alto common stock pursuant and/or traceable to the Offering Documents issued in connection with the Company’s initial public offering conducted on or about February 2, 2024; and/or (b) Alto securities between February 2, 2024 and October 22, 2024, both dates inclusive. Follow the link below to get more information and be contacted by a member of our team:
ANRO investors may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500.
CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (i) The Company’s product pipeline, ALTO-100, was less effective in treating major depressive disorder than defendants had led investors to believe; (ii) accordingly, ALTO-100’s clinical, regulatory, and commercial prospects were overstated; (iii) as a result, Alto’s business and/or financial prospects were overstated; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.
WHAT'S NEXT? If you suffered a loss in Alto Neuroscience, Inc. during the relevant time frame, you have until September 19, 2025 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
NO COST TO YOU: If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. There is no cost or obligation to participate.
WHY LEVI & KORSINSKY: Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services’ Top 50 Report as one of the top securities litigation firms in the United States.
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
33 Whitehall Street, 17th Floor

Tags

Frequently Asked Questions

What is the lawsuit against Alto Neuroscience about?

The lawsuit addresses alleged securities fraud impacting investors of Alto Neuroscience.

Who can join the Alto Neuroscience class action?

Anyone who purchased Alto stock from February 2, 2024, to October 22, 2024.

What must I do if I want to be a lead plaintiff?

You must request court appointment by September 19, 2025, to be a lead plaintiff.

Are there any costs to participate in the lawsuit?

There are no out-of-pocket costs for class members wishing to participate.

Why should I choose Levi & Korsinsky for this case?

Levi & Korsinsky has a proven track record in securities litigation and extensive expertise.

Last updated: Aug 25, 2025